Blencowe Resources: Aspiring to become one of the largest graphite producers in the world. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIofina Regulatory News (IOF)

Share Price Information for Iofina (IOF)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 20.50
Bid: 20.00
Ask: 21.00
Change: -0.25 (-1.20%)
Spread: 1.00 (5.00%)
Open: 20.75
High: 20.75
Low: 20.50
Prev. Close: 20.75
IOF Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Corporate Update

22 Jul 2020 07:00

RNS Number : 6870T
Iofina PLC
22 July 2020
 

 

22 July 2020

 

Iofina Plc

("Iofina" or the "Company")

(LSE AIM: IOF)

 

Corporate Update

 

Iofina, a specialist in the exploration and production of iodine and manufacturers of specialty chemical products, today provides an update to the market regarding H1 2020 iodine production, debt refinancing and other corporate matters.

 

H1 2020 Production

In H1 2020, Iofina produced 284.4 metric tonnes ("MT") of crystalline iodine of which 277.5 MT was produced by Iofina's four established iodine plants and 6.9 MT from IO#8. This production was in line with H1 2019 production of 286.7 MT. As previously communicated, IO#8 was briefly open in April for a few weeks, shut down in May, and reopened again in late June. The Company is still optimizing this new plant but expects IO#8 to run throughout the second half of 2020 and beyond. With all five plants running as normal, the Company is expecting total iodine production for H2 2020 to range between 340 and 360 MT of crystalline iodine. However, the Company notes that the ongoing uncertainty of the global pandemic does make production forecasting more difficult. Encouragingly, iodine prices have remained steady in Q2 2020 and into Q3 2020, with typical iodine prices now at $35/kg or above.

 

Debt Update

The Company continues to progress a debt refinancing package with a new lender. One of the principal objectives of this process has been, and remains, to repay the Company's current lenders (together, the "Secured Lenders") in full, who have supported the Company over the past several years. Unfortunately, the time required to complete the debt refinancing has been significantly impacted by events related to COVID-19. The new debt restructuring terms are likely to include a term loan as well as a revolving line of credit to meet Iofina's debt repayment obligations. Iofina will detail the final terms of the refinancing to the market once terms have been agreed. It is anticipated that the refinancing will be completed within the two-month extension recently granted by Iofina's current senior lender Stena Investments S.à.r.l. ("Stena"). Once the debt refinancing is complete, the Secured Lenders will be paid in full. As previously communicated, Iofina's junior lender, Southern Rock Insurance Company Limited ("SRICL"), has not agreed to a debt extension. Notwithstanding that the grace period for payment to SRICL concludes today, the Company will continue to progress the refinancing to facilitate its closing as soon as practicable and thereby ensure repayment in full to the Secured Lenders.

 

Pursuant to the terms of the security agreements previously negotiated and entered into between the Company and the Secured Lenders, Stena was appointed as security trustee, meaning that it holds the security interests granted over Iofina's assets on trust for itself and Southern Rock. The security interests granted by the Company, both in the UK and US, are registered in the name of Stena under this arrangement. As security trustee, any enforcement over the Company's assets in respect of it not having repaid the debt that has become due would require action by Stena. Stena, having agreed to the extension, has reiterated its continued support for the Company for which the Board is particularly grateful, specifically as the Company seeks to bring its refinancing negotiations to a successful close.

 

The Company owes approximately US$15.45m to the Secured Lenders, of which the amount owing to SRICL amounts to approximately US$1.2m. The outstanding debt is repayable on a pro rata basis. The Company's current cash balance is approximately US$5.3m, and the Directors firmly believe that the Company remains in a strong position, both insofar as it pertains to current business outlook but more specifically with regard to its refinancing efforts.

 

Other Items

Iofina anticipates that in Q3 2020 it will apply for loan forgiveness for Payroll Protection Program ("PPP") loans totalling US$1.09m, which were used for payroll expenses to maintain full employment during the current pandemic. The Company expects all of the PPP loans to be forgiven in H2 2020.

 

Iofina's continues to monitor carefully its investment in the hemp seed joint venture with Organic Vines OP (the "JV"). Hemp seed sales from seed suppliers across the USA have been much lower than expected due to the uncertainty of COVID-19 combined with the lack of a comprehensive USA hemp crop insurance program available to all farmers. Planting in the USA this year has declined nearly 60 percent compared to 2019 hemp planting and, to date, the seed sales from the JV through its sales partner have been much lower than expected. It is not clear when the seed sales will complete, but it appears that sales are likely to continue into 2021, as a significant portion of seed is likely to be sold into international markets. The Company will update the market on the progress of hemp seed sales from this JV in due course.

 

 

Commenting, President and CEO of Iofina Dr. Tom Becker, stated: "The first half of 2020 has been difficult for everyone, but Iofina's performance has been solid in spite of the difficult events affecting the world. Iodine prices have remained robust and our production levels compare well with 2019 and, with IO#8 now online, H2 2020 iodine production is expected to surpass H1 2020 production totals.

 

"We are pleased to continue to progress towards the completion of our debt refinancing which will provide us with a clean slate and allow us to dedicate more focus towards maximising our fantastic growth opportunities in iodine and continuing to generate shareholder value."

 

Enquiries:

 

Dr. Tom Becker

CEO & President

Iofina plc

Tel: +44 (0)20 3006 3135

 

Christopher Raggett/Giles Rolls/Matthew Radley (corporate finance)

Tim Redfern (ECM)

finnCap Ltd

Tel: +44 (0)20 7220 0500

 

Media Contact:

Charles Goodwin/Joe Burgess

Yellow Jersey PR Limited

Tel: +44 (0)20 3004 9512

About Iofina:

Iofina plc (AIM: IOF) is a vertically integrated Company that specialises in the production of Iodine and the manufacturing of specialty chemical products. As the second largest producer of iodine in North America, it comprises three USA entities; Iofina Resources, Iofina Chemical and IofinaEX.

 

LEI: 213800QDMFYVRJYYTQ84

ISIN: GB00B2QL5C79

 

Iofina Resources

Iofina Resources develops, builds, owns and operates iodine extraction plants using Iofina's WET® IOsorb® technology. Iofina currently operates five producing IOsorb® plants in Oklahoma and is consistently using technology and innovation to improve and expand its operations.

 

Iofina Chemical

Iofina Chemical has manufactured high quality halogen speciality chemicals derived from raw iodine, as well as non-iodine based products for over 35 years.

 

IofinaEX

Iofina's newest subsidiary, IofinaEX, is fully licensed to process hemp in the state of Kentucky and is exploring the isolation of specialty chemical products from hemp, a rapidly expanding market.

 

www.iofina.com

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDFZGZNGMNGGZZ
Date   Source Headline
2nd May 20247:00 amRNSFinal Results
16th Apr 20247:00 amRNSQ1 2024 Corporate Update
17th Jan 20247:00 amRNSHolding(s) in Company
15th Jan 20247:00 amRNSQ4 2023 Corporate Update
30th Nov 20237:00 amRNSIO#9 Update
20th Oct 20237:00 amRNSSigned Agreement for IO#10 and Q3 2023 Update
11th Sep 20237:00 amRNSInterim Results
25th Aug 20235:00 pmRNSHolding(s) in Company
24th Jul 20235:00 pmRNSHolding(s) in Company
20th Jul 20237:00 amRNSH1 Update and Updated Loan Facilities
14th Jun 20232:00 pmRNSResult of AGM
14th Jun 20237:00 amRNSIO#9 Iodine Plant Operating
9th May 20237:00 amRNSNotice of AGM
4th May 20237:00 amRNSInvestor Presentation
28th Apr 20234:45 pmRNSHolding(s) in Company
28th Apr 20237:00 amRNSGrant of Share Options
25th Apr 20237:00 amRNS2022 FULL YEAR RESULTS
12th Apr 20237:00 amRNSProduction Update
20th Feb 20237:00 amRNSDirector/PDMR Shareholding
6th Feb 20237:00 amRNSTrading Update
9th Jan 20237:00 amRNSMarket Update
28th Dec 20222:34 pmRNSHolding(s) in Company
14th Dec 20227:00 amRNSIofina Chemical Awarded ISO Certification
21st Nov 20227:00 amRNSChange of Adviser
28th Oct 20227:00 amRNSFinalised Terms for IO9 & Q3 Production Update
26th Sep 202211:06 amRNSSecond Price Monitoring Extn
26th Sep 202211:00 amRNSPrice Monitoring Extension
26th Sep 20227:00 amRNSInterim Results
8th Jul 20227:00 amRNSAdditional Loan Facilities and H1 Update
5th Jul 20228:54 amRNSHolding(s) in Company
22nd Jun 20222:30 pmRNSResult of AGM
20th Jun 20227:00 amRNSAppointment of Chrystal Capital Partners LLP
27th May 20227:00 amRNSNotice of AGM
26th May 20224:15 pmRNSHolding(s) in Company
26th May 20222:15 pmRNSHolding(s) in Company
24th May 20226:15 pmRNSHolding(s) in Company
20th May 20227:10 amRNSInvestor Presentation
18th May 20227:00 amRNSHolding(s) in Company
9th May 20227:00 amRNSFinal Results
5th May 20227:00 amRNSHolding(s) in Company
28th Apr 20228:38 amRNSHolding(s) in Company
19th Apr 20227:00 amRNSQ1 2022 and IO#9 Update
8th Apr 20221:07 pmRNSHolding(s) in Company
17th Mar 20227:00 amRNSDirector/PDMR Shareholding
16th Mar 20227:00 amRNSHolding(s) in Company
14th Mar 20227:00 amRNSDirector/PDMR Shareholding
11th Mar 20227:00 amRNSDirector/PDMR Shareholding
10th Mar 20227:00 amRNSDirector/PDMR Shareholding
9th Mar 20227:00 amRNSGrant of Share Options
8th Mar 20228:51 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.